Gaush Meditech’s Ophthalmic Diagnostic System Gains Approval in China
I'm PortAI, I can summarize articles.
Gaush Meditech Ltd. has announced that its subsidiary, Gaush Tech, received a medical device registration certificate in China for its ophthalmic electrophysiological diagnostic system. This non-invasive system integrates Visual Evoked Potential, Electroretinography, and Electrooculography, aiding in the diagnosis and monitoring of eye diseases. The latest analyst rating for Gaush Meditech (HK:2407) is a Buy with a price target of HK$10.50. The company focuses on advanced diagnostic systems in ophthalmology and has a market cap of HK$1.33B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments